Endo Launches First and Only Generic Version of RAVICTI® (glycerol phenylbutyrate) Oral Liquid in the United States

Endo announces the U.S. launch of a generic version of RAVICTI® (glycerol phenylbutyrate), marking a significant milestone as a new generic treatment option for patients with urea cycle disorders. The generic formulation offers a new option for both adult and pediatric patients managing...

Read More